Researchers found that older adults who received AS01-adjuvanted shingles or RSV vaccines had a significantly lower risk of ...

New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...

Nokian’s Surpass AS01 is a new all-season tire designed with low rolling resistance and comfort in mind. That’s due, in part, to there being more silica in the rubber compound of the AS01 than ...

Two AS01-adjuvanted vaccines for different pathogens -- the respiratory syncytial virus (RSV) vaccine (Arexvy) and the ...

Individuals who received either the AS01 shingles or RSV vaccine had a significantly lower risk of developing dementia.

We sampled the AS01 on two sporty-but-not-outright-fast sedans—a Mercedes-Benz C300 and an electric Polestar 2. We then moved to a time trial run with the Surpass AS01 fitted to a Toyota GR ...

An ongoing phase 3 study of the efficacy, safety, and immunogenicity of candidate malaria vaccine RTS,S/AS01 is being conducted in seven African countries.From March 2009 through January 2011, we e ...

Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.

The Nokian Surpass AS01 is an ultra-high-performance all-season tire with a 55,000-mile warranty, designed for stability and comfort. Tested on a track, it offers predictable handling and durability.

The Surpass AS01 isn't the first ultra-high-performance tire from Nokian—that would be the zLine A/S—but it's the first time Nokian has offered a tire in this segment in a few years.